Mammary Carcinoma Incidence in Mice After Ovariectomy and Oestrone Treatment
Author Information
Author(s): B. D. Pullinger
Primary Institution: Royal Beatson Memorial Hospital, Glasgow
Hypothesis
Does the substitution of oestrone after ovariectomy affect the incidence of mammary carcinoma in C3Hf female mice?
Conclusion
The study found that substitution of oestrone did lead to a slight increase in mammary carcinoma incidence, but the overall effect was limited.
Supporting Evidence
- The spontaneous incidence of mammary carcinoma in intact virgin females was 2 in 115.
- Only one mammary carcinoma arose in 34 ovariectomized females treated with oestrone.
- No adrenal cortical tumours developed after substitution of oestrone and progesterone.
Takeaway
When female mice had their ovaries removed and were given a hormone called oestrone, only a few got breast cancer, showing that hormones can affect cancer risk.
Methodology
The study involved observing four groups of mice: intact, ovariectomized with no treatment, ovariectomized with oestrone, and ovariectomized with oestrone and progesterone.
Limitations
The low spontaneous incidence of mammary carcinoma in the mouse strain limited the ability to draw definitive conclusions.
Participant Demographics
C3Hf female mice, virgin, aged 8 to 10 weeks at the start of the experiment.
Want to read the original?
Access the complete publication on the publisher's website